CClinicalTrials.gg
Not yet recruitingNCT07129109SQLNS:7Dv1DUpdated Jul 10, 2026

Assessing the Performance of 7-Day vs 1-Day Packaging for Small Quantity Lipid-Based Nutrient Supplements in Ghana (SQLNS:7D-1D Comparison)

An interventional study of small-quantity lipid-based nutrient supplements (SQ-LNS) in Child Malnutrition, sponsored by Boston University Charles River Campus. Not yet recruiting at 1 site in Ghana. Per ClinicalTrials.gov, last updated 2026-07-10.

Sponsored by Boston University Charles River Campus · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
505
Allocation
Randomized
Sex
All
01

Study summary

This cluster-randomized crossover trial evaluates the impact of two different packaging formats for small-quantity lipid-based nutrient supplements (SQ-LNS) on adherence and acceptability among caregivers of young children in Northern Ghana. SQ-LNS are a proven intervention for reducing child malnutrition, but optimizing packaging formats may improve adherence and scalability.

Sixteen health facilities participating in growth monitoring services will each receive both formats: a 1-day sachet (20g daily) and a 7-day bulk container (140g weekly), with the order of delivery randomized. Each packaging format will be distributed for one month before cross-over. The primary outcomes are adherence (measured through caregiver self-report and sachet counts) and acceptability (assessed via caregiver interviews). Secondary outcomes include caregiver preference, ease of use, and qualitative insights into feeding practices, beliefs, and packaging usability.

This implementation research study uses a convergent mixed-methods design, integrating quantitative adherence and acceptability data with in-depth interviews and structured observations to inform real-world program implementation. Findings will guide policy and program decisions for integrating SQ-LNS into child health platforms in Ghana and other low-resource settings.

Read the detailed description

Background and Rationale:

Small-quantity lipid-based nutrient supplements (SQ-LNS) have demonstrated effectiveness in reducing child undernutrition, including stunting, wasting, and anemia, particularly among children 6-24 months of age in low- and middle-income countries. Despite strong evidence, uptake and adherence in real-world settings remain suboptimal. Packaging format may influence how caregivers understand, use, and integrate SQ-LNS into daily routines.

This study, titled "Assessing the performance of 7-day vs 1-day packaging for Small Quantity Lipid-based Nutrient Supplements in Ghana," is designed to evaluate how packaging format influences adherence and acceptability when SQ-LNS are distributed through routine growth monitoring services in Northern Ghana.

Study Objectives:

Primary Objective: To compare adherence to SQ-LNS when delivered in 1-day sachets versus 7-day bulk packaging.

Secondary Objectives: To assess caregiver acceptability, preferences, ease of use, and perceptions of both packaging types; and to explore implementation facilitators and barriers to effective delivery and use of SQ-LNS within growth monitoring programs.

Study Design:

This is a cluster-randomized crossover trial embedded within routine child health services at eight health facilities. The trial follows a convergent mixed-methods implementation research design.

Clusters: Health facilities (n=16), each randomized to one of two packaging sequences.

Intervention: Each facility receives one packaging format for one month, then switches to the alternate format for another month.

Participants: Caregivers of children aged 6-24 months attending growth monitoring and promotion (GMP) services during the intervention periods.

Randomization:

Facilities are randomized to one of two sequences:

Sequence A: 1-day sachet → 7-day bulk Sequence B: 7-day bulk → 1-day sachet Randomization is stratified by facility size or service volume (if available) to ensure balance.

Sample Size:

Based on prior service utilization data and expected recruitment rates, the study aims to enroll approximately 250 caregivers per arm.

Outcomes:

Primary Outcomes: Adherence to SQ-LNS (measured by caregiver self-report, sachet count, and possibly biomarkers or stool colorant testing if available)

Secondary Outcomes:

Caregiver acceptability and preference (structured surveys and Likert scales) Usability and ease of administration Qualitative themes related to packaging, feeding practices, and caregiver experience (in-depth interviews and structured observations)

Data Collection:

Quantitative data will be collected through baseline and endline caregiver surveys, adherence logs, and observational checklists.

Qualitative data will be collected through purposive sampling of caregivers for in-depth interviews, as well as interviews with health workers and program implementers.

Analysis Plan:

Quantitative data will be analyzed using generalized linear mixed models to account for clustering and crossover design. Primary comparisons will assess differences in adherence between packaging formats. Qualitative data will be coded and analyzed thematically using a grounded theory approach. Convergence of quantitative and qualitative data will inform implementation recommendations.

Ethical Considerations:

The study will be submitted for IRB approval from received approval from Boston University and the University of Ghana. Written informed consent will be obtained from all participants. The study poses minimal risk and is embedded in routine health services.

Dissemination:

Findings will be shared with Ghana Health Service, implementing partners, and international stakeholders, and will be submitted for publication in peer-reviewed journals.

02

Conditions studied

  • Child Malnutrition

Keywords

  • Small-quantity lipid-based nutrient supplements (SQ-LNS)
  • Ghana
  • Infant and young child feeding
  • Growth monitoring and promotion (GMP)
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Primary caregiver of a child aged 6-24 months attending growth monitoring and promotion (GMP) services at one of the participating health facilities
  • Willing and able to provide informed consent
  • Plans to remain in the area for the duration of the study period
  • Agrees to participate in surveys and/or interviews related to supplement use

Exclusion criteria

Exclusion Criteria:

  • Caregiver of a child with a diagnosed severe illness requiring hospitalization
  • Caregiver under the age of 18
04

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
505 participants (estimated)

Study arms

  • Active comparator
    SQ-LNS 1-day packaging first, followed by 7-day packaging

    SQ-LNS 1-day packaging first, followed by 7-day packaging

    Dietary Supplement: small-quantity lipid-based nutrient supplements (SQ-LNS)

  • Experimental
    SQ-LNS 7-day packaging first, followed by 1-day packaging

    SQ-LNS 7-day packaging first, followed by 1-day packaging

    Dietary Supplement: small-quantity lipid-based nutrient supplements (SQ-LNS)

Interventions

  • Dietary supplementsmall-quantity lipid-based nutrient supplements (SQ-LNS)

    All caregivers will receive 2 months of SQ-LNS in this cross-over design. Half of the participants will be randomized to receive the 7-day packaging first, and half will receive the 1-day packaging first.

05

What researchers measure

Primary outcomes

  1. Adherence

    Adherence will be defined as the percentage of the 28-day dose of small quantity lipid-based nutrient supplements (SQ-LNS) consumed, measured using a triangulated approach that combines caregiver report with returned-sachet counts and residual-sachet weighing.

    Time frame: Measured twice per participant: at the end of the first 1-month phase and at the end of the second 1-month phase

Secondary outcomes

  1. Caregiver acceptability/usability

    Caregiver acceptability/usability will be defined as a composite score (Likert-scaled) capturing acceptability, preference, usability, and ease of administration of the SQ-LNS packaging

    Time frame: Measured twice per participant: at the end of the first 1-month phase and at the end of the second 1-month phase

  2. Caregiver experience with SQ-LNS

    Qualitative assessment of caregiver experience with SQ-LNS, including perceptions of packaging, feeding practices, and overall acceptability, collected through semi-structured interviews and analyzed using thematic content analysis.

    Time frame: At the end of each 1-month crossover period (following each intervention phase)

06

Study locations

1 site
  • Sixteen health facilities in the Northern Region of Ghana (exact sites TBD)
    Tamale, Ghana
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07129109
Lead sponsor
Boston University Charles River Campus
Collaborators
University of Ghana, Edesia Nutrition
Responsible party
Sponsor
First posted
Aug 19, 2025
Start date
Sep 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jul 10, 2026

Study contacts

Lindsey M Locks, ScD
Contact
lmlocks@bu.edu
617-353-2710
Lindsey Locks, ScD
principal investigator · Bostson University Charles River Campus

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion